Compare PRGO & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRGO | TSLX |
|---|---|---|
| Founded | 1887 | 2010 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2013 | 2011 |
| Metric | PRGO | TSLX |
|---|---|---|
| Price | $11.27 | $17.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $19.33 | ★ $21.61 |
| AVG Volume (30 Days) | ★ 2.4M | 763.7K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | 10.28% | ★ 10.82% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.02 | $1.20 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.23 | $16.96 |
| 52 Week High | $28.44 | $25.17 |
| Indicator | PRGO | TSLX |
|---|---|---|
| Relative Strength Index (RSI) | 51.54 | 39.65 |
| Support Level | $11.26 | $17.26 |
| Resistance Level | $12.36 | $18.65 |
| Average True Range (ATR) | 0.46 | 0.42 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 59.85 | 28.05 |
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.